2025-01-16
RI039, RNase Inhibitor, Human Placenta,I.e. Ribonuclease Prohibitor, Human Placenta is a recombinant expression of human placental RNase inhibitor in Escherichia coli, which can bind to RNase A, RNase B, RNase C, and human placental RNase in a non competitive 1:1 ratio and inhibit their activity, thereby protecting RNA from degradation by these enzymes.
2025-01-13
RN01, RNase H, Recombinant
is a ribonucleic acid endonuclease that specifically breaks down RNA strands in RNA DNA hybrids, and cannot digest single or double stranded DNA.
2022-05-21
RA02, Recombinant Ribonuclease A (RNase A) Solution (Animal free), solution. Animal free, DNase free, host DNA free. 10mg/ml, Activity>=350KU/ml. DNA extraction or RNA sequencing
2022-04-01
RA03, Recombinant Ribonuclease A (RNase A) Lyophilized Powder (Animal free), DNase free, host DNA free. Activity>=40KU/mg. DNA extraction or RNA sequencing
2021-12-24
RA01, Pancreatic Ribonuclease, Activity>= 50 KU/mg peotein, Lyophilized Powder, Ribonuclease A, RNase A, RNase 1, DNase free
2021-12-22
RNK3501, GMP-RI01, recombinant Murine Ribonuclease Inhibitor, 40U/μl, GMP Grade, for medical mRNA synthesis and other biopharmaceutical production, 40U/μl*75μl/vial